Improving the Tolerability of Anticholinergic Agents in the Treatment of Overactive Bladder

ISSN： 0114-5916

Source： Drug Safety, Vol.28, Iss.7, 2005-01, pp. : 583-600

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and Tolerability Profiles of Anticholinergic Agents Used for the Treatment of Overactive Bladder

By Oefelein Michael G.

Drug Safety, Vol. 34, Iss. 9, 2011-09 ,pp. : 733-754

Adis International

Access to resources Recommend Favorite

Trospium chloride: an anticholinergic quaternary ammonium compound for the treatment of overactive bladder

By Zinner Norman R

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 8, 2005-07 ,pp. : 1409-1420

Informa Healthcare

Access to resources Recommend Favorite

Effect of Anticholinergic Use for the Treatment of Overactive Bladder on Cognitive Function in Postmenopausal Women

By Geller Elizabeth J.

Clinical Drug Investigation, Vol. 32, Iss. 10, 2012-10 ,pp. : 697-705

Adis International

Access to resources Recommend Favorite

Twelve-Month Treatment of Overactive Bladder: Efficacy and Tolerability of Tolterodine

By Abrams P.

Drugs & Aging, Vol. 18, Iss. 7, 2001-01 ,pp. : 551-560

Adis International

Access to resources Recommend Favorite

Pharmacological agents for the treatment of urinary incontinence due to overactive bladder

By Wein A.J.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 1, 2001-01 ,pp. : 65-83

Informa Healthcare

Access to resources Recommend Favorite